Five flavonoids, one isoflavone and five xanthones were isolated from Anaxagorea luzonensis. Of these eleven isolated compounds, 1,3,5-trihydroxy-4-prenylxanthone (3) was a relatively potent inhibitor of phosphodiesterase type 5 (PDE5), with an IC 50 value of 3.0 µM. This is the first report showing that natural xanthones can exhibit promising PDE5 inhibitory activity. Moreover, this study revealed that the presence of the C-4 prenyl residue attached to the xanthone core is correlated with the significant PDE5 inhibitory activity.
Cyclic nucleotide phosphodiesterases (PDEs) are enzymes which are widely found in mammalian tissues and organs. They are responsible for regulating cyclic nucleotide levels by catalyzing the hydrolysis and inactivation of the secondary messengers, cyclic guanosine monophosphate (cGMP) and cyclic adenosine monophosphate (cAMP). Many diseases are related to the reduced concentration or short-time duration of cyclic nucleotides in tissues or organs, such as asthma, erectile dysfunction in men, diabetes and Alzheimer's disease [1] . Thus, PDE inhibitors have emerged as potential therapeutic agents in the treatment of various diseases, depending upon their potency and specificity. Sildenafil (Viagra) is a PDE5 inhibitor that is clinically used for the oral treatment of male erectile dysfunction, pulmonary hypotension and cardioprotection [2, 3] . Sildenafil increases the level of cGMP and, therefore, induces vascular smooth muscle relaxation. The blood influx into the penile tissue is increased and results in an erection of the penis [4] . However, several side effects have been recorded in clinical trials of Sildenafil and other PDE5 inhibitors, including visual disturbance, nausea and headache. Thus, the search for PDE5 inhibitors from natural sources might lead to the identification of new therapeutic agents with less adverse effects, or to a greater understanding of the structure-function relationship of specific PDE isoenzyme inhibitors and new templates for subsequent modifications to improve their specificity or potency.
Anaxagorea luzonensis A. Gray is an Annonaceae plant found in Thailand. Its heartwoods have been used for the relief of tendon and muscular pain, and also to enhance the blood flow in the body [5] . The dichloromethane (CH 2 Cl 2 ) extract of A. luzonensis has been reported to have vasorelaxant effects via inducing endotheliumderived nitric oxide production and the inhibition of Ca 2+ influx in the isolated rat aorta [6] . This effect might be caused by increasing the cGMP and cAMP level(s), but this assumption has not yet been tested and the active compound(s) have not been isolated and identified. Previous phytochemical studies have revealed an abundant diversity of various xanthones and flavonoids in this plant [7] [8] [9] [10] [11] . The prenylated flavonoid 8-prenylnaringenin was shown to possess a strong estrogenic action [7] , and 3,5,7,4-tetrahydroxy-2-methoxyflavone showed a high anti-oxidant activity towards DPPH radicals [8] . Moreover, 1,3,5-trihydroxy-4-prenylxanthone (3) inhibited acetyl-and butyryl-cholinesterase with IC 50 values of 56 and 46 µM, respectively [11] .
According to the assumption that the vasorelaxation effect of A. luzonensis extract was related to altered cGMP levels, the heartwood extract of this plant was preliminary tested for PDE5 inhibition. Since the extract was found to exhibit a PDE5 inhibition activity of 77% at 50 µg/mL, the plant extract was further fractionated to determine the active component(s).
In this study, 15 compounds were isolated from the A. luzonensis extract and comprised five xanthones (1-5), five flavonoids (6, 8-11) and one isoflavonoid (7) (Figure 1 ). The PDE5 inhibitory activity of all isolated compounds was tested and the results are summarized in Table 1 . All the isolated compounds showed PDE5 inhibitory activity in a potentially dose-dependent manner. The flavonoids and isoflavone showed a low to mild cGMP PDE5 inhibitory activity ranging from 10-70% and 7.8-38% inhibition at 100 and 10 µM, respectively, and so the IC 50 values (concentration of compound resulting in a 50% inhibition of PDE5 activity) were not evaluated. However, a tentative structure-activity comparison, based on the % inhibitory activity, was performed and revealed that flavonoids having a C 2,3 double bond inhibited the PDE5 isolated from mice lung tissues more potently than those without the C 2,3 double bond (compare kaempferol vs. aromadendrin and quercetin vs. taxifolin). This result is in agreement with previous reports that the absence of a C 2,3 double bond in flavonoids diminished the PDE inhibition level [12, 13] . The C-3 hydroxyl group of flavanones also seemed to diminish the PDE5 potency (aromadendrin vs. taxifolin), which was in contrast to that previously reported for flavones [14] . In addition, the C-3 hydroxyl group of flavonols was reported to reduce the PDE5 Inhibition potency [14] , but in this study the presence of the C-3 hydroxyl group in these flavanones did not markedly alter their inhibitory ability against PDE5 (aromadendrin vs. naringenin).
Orobol, which was the only isoflavone isolated from this A. luzonensis extract, showed mild PDE5 inhibition activity. Quercetin, kaempferol and naringenin have previously been reported to possess PDE5 inhibitory activity, where, using a scintillation proximity assay, quercetin and kaempferol inhibited recombinant PDE5A in the same micromolar range as that of zaprinast [14] , a cGMP-specific PDE inhibitor. Moreover, quercetin showed a higher inhibition towards the PDE isolated from the epididymal adipose tissue of male Wistar rats than 3-isobutyl-1-methylxanthine, while kaempferol possessed a lower activity [15] . Naringenin was reported to inhibit the PDE1, PDE4 and PDE5 isoenzymes isolated from bovine aorta with IC 50 values in the range of 40-70 M [16] .
Among the isolated xanthones, those containing C-4 prenyl/hydroxylated prenyl groups (3 and 4) showed reasonably good PDE5 inhibitory activities with IC 50 values around 3 µM. However, this is still more than 400-fold higher than that observed for sildenafil. Although their potency is, therefore, much lower than sildenafil, this is the first report of this class of compounds as potential PDE5 inhibitors. Structure modification of these compounds might lead to the development of more potent inhibitors with respect to each target PDE isozyme. The presence of a prenyl group at the C-4 position was potentially important for the PDE5 inhibitory activity since the inhibition was markedly (~11-to 18-fold) lower in 2 and 5. In addition, when the prenyl group was cyclized, as in 1, the PDE5 inhibitory activity was decreased by an order of magnitude compared to the non-cyclized derivative 3. The presence of either a double bond or a hydroxy group between C-12 and C-13 of the prenyl group and the C-5 -OMe group appeared to have no significant affect upon the PDE5 inhibitory activities.
There have been no previous reported studies that evaluated the anti-PDE5 activity of xanthones, and only a few published data on the inhibition of other PDE isozymes by xanthones [16, 17] . In this study, we report for the first time that the C-4 prenyl group is likely to be a vital moiety for PDE5 inhibitory activity of the xanthone structure.
In conclusion, among the 11 isolated compounds from A. luzonensis, the prenylated xanthone 3 exerted the highest PDE5 inhibitory activity and, therefore, might have the greatest potential as an agent for the treatment of erectile dysfunction. The main Quercetin (6) 50.4 ± 0.3 38.0 ± 0.9 n.d naringenin (8) 47.5 ± 0.5 8.4 ± 0.2 n.d aromadendrin (9) 34.1 ± 0.4 9.0 ± 1.8 n.d taxifolin (10) 14.0 ± 0.6 7.8 ± 2.3 n.d kaempferol (11) 62.6 ± 0.7 24.0 ± 4.5 n.d Isoflavones orobol (7) 67.8 ± 0. [11] . Additionally isolated flavonoids are described herein. Quercetin (6, 110.5 mg) [18] was obtained from the same fraction as 1 of the CH 2 Cl 2 extract. Fraction B4-2 of the butanol extract afforded orobol (7, 410.4 mg) [19] , naringenin (8, 46 .3 mg) [20] , aromadendrin (9, 91.6 mg) [21] and taxifolin (10, 320.02 mg) [22] by Sephadex LH-20 column chromatography (CC) eluted with methanol. Finally, the third sub-fraction from fraction B4-3 yielded kaempferol (11, 78.1 mg) [18] by Sephadex LH-20 CC eluted with 1:1 (v/v) ratio of chloroform: methanol.
PDE5 inhibitory assay:
Enzyme preparation from mice lung tissues and determination of the PDE5 inhibitory activity was performed as previously reported [23] .
